New book by Larry Connors Click here Improve your trading - See how
Interim report 1 January - 30 June 2009
- Net sales amounted to SEK 112.4 million (72.4), an increase of SEK 40.0 million (55%).
- Operating profit was SEK 29.9 million (12.6), an increase of SEK 17.3 million.
- Profit before tax was SEK 31.3 million (13.6), an increase of SEK 17.7 million.
- Due to earlier cumulative loss carry forward BioGaia pays no tax. Profit after reported tax was SEK 21.6 million (22.1), a decrease of SEK 0.5 million. The period's reported tax expense of SEK 9.7 million refers to a change in the deferred tax asset. Profit for the corresponding period of last year included a tax benefit of SEK 8.5 million.
- Earnings per share were SEK 1.26 (1.29).
- The period's cash flow from operating activities before change in working capital was SEK 32.1 million (16.2). Total cash flow for the period was SEK 10.9 million (5.0). Cash and cash equivalents at 30 June 2009 amounted to SEK 69.0 million.
Second quarter, 1 April - 30 June 2009
- Net sales for the second quarter amounted to SEK 60.2 million (36.4), an increase of SEK 23.8 million (65%) over the same period of last year. Compared to the first quarter, net sales rose by SEK 8.0 million.
- Operating profit was SEK 16.6 million (5.0), an increase of SEK 11.6 million.
- Profit before tax was SEK 16.2 million (5.6), an increase of SEK 10.6 million.
- Due to earlier cumulative loss carry forward BioGaia pays no tax. Profit after reported tax was SEK 11.2 million (14.1), a decrease of SEK 2.9 million. The period's reported tax expense of SEK 5.0 million refers to a change in the deferred tax asset. Profit for the corresponding period of last year included a tax benefit of SEK 8.5 million.
Key events in the second quarter of 2009
- Distribution agreement with InfectoPharm for the sale of BioGaia's Probiotic drops in Germany.
- Agreement with Semper for the sale of probiotic oral rehydration solution in Sweden and Norway.
No key events have taken place after the end of the reporting period.
"We are seeing excellent results from our efforts, with year-on-year sales growth of 55% for the first six months. Even if one takes into account earlier than schedule deliveries for SEK 5.4 million and positive exchange rate effects, sales are increasing very satisfactorily. Furthermore I am very happy that we have succeeded in maintaining our gross margins and above all in containing our fixed costs," says Managing Director Peter Rothschild.
Latest press releases from BioGaia: 2009-06-30 BioGaia signs new agreement with Semper for unique probiotic oral rehydration solution 2009-06-11 BioGaia signs distribution agreement in Germany 2009-04-23 Annual General Meeting of BioGaia
For additional information contact: Peter Rothschild, Managing Director, telephone +46 8 - 555 293 00 Jan Annwall, Deputy Managing Director, telephone +46 8 - 555 293 00
This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
SOURCE: BioGaia AB
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
